SCIENCE BRIEFS.
Informing Ontario’s response to COVID-19
Science Brief Categories
- Epidemiology, Public Health & Implementation
- Health Equity & Social Determinants of Health
- Infectious Diseases & Clinical Care
- Public Policy & Economic Impact
Epidemiology, Public Health & Implementation
-
Ontario Returns to School: An Overview of the Science
-
Ask Ontario’s Science Table: Omicron Edition
-
Update on COVID-19 Projections
-
Rapid Antigen Tests for Voluntary Screen Testing
-
Update on COVID-19 Projections
Health Equity & Social Determinants of Health
-
Burnout in Hospital-Based Healthcare Workers during COVID-19
-
Ontario’s Community-Dwelling Older Adults Who Remain Unvaccinated Against COVID-19
-
COVID-19 Vaccination for People with Disabilities
-
A Vaccination Strategy for Ontario COVID-19 Hotspots and Essential Workers
-
Mobile In-Home COVID-19 Vaccination of Ontario Homebound Older Adults by Neighbourhood Risk
Infectious Diseases & Clinical Care
-
Fluvoxamine: What Prescribers and Pharmacists Need to Know
-
Baricitinib for Hospitalized Patients with COVID-19
-
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
-
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
-
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19
Public Policy & Economic Impact
-
COVID-19 Vaccine Mandates for Ontario’s Hospital Workers: Response to the Premier of Ontario
-
COVID-19 Vaccine Certificates: Key Considerations for the Ontario Context
-
School Operation for the 2021-2022 Academic Year in the Context of the COVID-19 Pandemic
-
COVID-19 and Education Disruption in Ontario: Emerging Evidence on Impacts
-
Response to the Premier of Ontario